πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7407658

Vaccines for blocking transmission of plasmodium vivax

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7408075

Synthesis of phosphocholine ester derivatives and conjugates thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7407935

Ricin toxin A-chain fragment for use as a vaccine

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7407664

Peptide vaccines against group A streptococci

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Aug 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7404961

Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family protei

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7402567

Treatment of disease by inducing cell apoptosis

The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel (024) Β· Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7402659

Thymic stromal lymphopoietin receptor molecules and uses thereof

THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted Tue Jul 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7399827

Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7388089

Anti-arthropod vector vaccines method of selecting and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7384978

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation Β· Granted Tue Jun 10 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7381744

Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7381405

Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 03 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378097

Use of penetration enhancers and barrier disruption methods to enhance the immune response

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378403

Akt inhibitors, pharmaceutical compositions, and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378277

Methods and compositions for transforming dendritic cells and activating T cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378276

Method of inducing memory B cell development and terminal differentiation

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378257

Bacterial superantigen vaccines

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7378093

Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus select

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 27 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7374756

Specific binding agents for KSHV vIL-6 that neutralize a biological activity

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7375185

Cardiac myosin light chain kinase polypeptide, encoding nucleic acid, and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7375079

Previns as specific inhibitors and therapeutic agents for botulinum toxin B and tetanus ne

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7374931

Vaccine against staphylococcus intoxication

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7374872

CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7371821

Cloning and expression of the full length 110 kDa antigen of Orientia tsutsugamushi to be

United States of America as represented by the Secretary of the Air Force Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted